Literature DB >> 34541223

Efficient Generation of Multi-gene Knockout Cell Lines and Patient-derived Xenografts Using Multi-colored Lenti-CRISPR-Cas9.

Lena Behrmann1, Scott McComb1,2, Júlia Aguadé-Gorgorió1, Yun Huang1, Mario Hermann3, Pawel Pelczar3,4, Adriano Aguzzi5, Jean-Pierre Bourquin1, Beat C Bornhauser1.   

Abstract

CRISPR-Cas9 based knockout strategies are increasingly used to analyze gene function. However, redundancies and overlapping functions in biological signaling pathways can call for generating multi-gene knockout cells, which remains a relatively laborious process. Here we detail the application of multi-color LentiCRISPR vectors to simultaneously generate single and multiple knockouts in human cells. We provide a complete protocol, including guide RNA design, LentiCRISPR cloning, viral production and transduction, as well as strategies for sorting and screening knockout cells. The validity of the process is demonstrated by the simultaneous deletion of up to four programmed cell death mediators in leukemic cell lines and patient-derived acute lymphoblastic leukemia xenografts, in which single cell cloning is not feasible. This protocol enables any lab with access to basic cellular biology equipment, a biosafety level 2 facility and fluorescence-activated cell sorting capabilities to generate single and multi-gene knockout cell lines or primary cells efficiently within one month.
Copyright © 2017 The Authors; exclusive licensee Bio-protocol LLC.

Entities:  

Keywords:  CRISPR; Cas9; Lentivirus; Multiple gene knockout; Primary human leukemia; Xenograft; sgRNA design

Year:  2017        PMID: 34541223      PMCID: PMC8410427          DOI: 10.21769/BioProtoc.2222

Source DB:  PubMed          Journal:  Bio Protoc        ISSN: 2331-8325


  26 in total

1.  Biological significance of a family of regularly spaced repeats in the genomes of Archaea, Bacteria and mitochondria.

Authors:  F J Mojica; C Díez-Villaseñor; E Soria; G Juez
Journal:  Mol Microbiol       Date:  2000-04       Impact factor: 3.501

2.  Identification of genes that are associated with DNA repeats in prokaryotes.

Authors:  Ruud Jansen; Jan D A van Embden; Wim Gaastra; Leo M Schouls
Journal:  Mol Microbiol       Date:  2002-03       Impact factor: 3.501

3.  Xenografts of highly resistant leukemia recapitulate the clonal composition of the leukemogenic compartment.

Authors:  Maike Schmitz; Petra Breithaupt; Nastassja Scheidegger; Gunnar Cario; Laura Bonapace; Barbara Meissner; Paulina Mirkowska; Joelle Tchinda; Felix K Niggli; Martin Stanulla; Martin Schrappe; Andre Schrauder; Beat C Bornhauser; Jean-Pierre Bourquin
Journal:  Blood       Date:  2011-06-13       Impact factor: 22.113

4.  Genome-scale CRISPR-Cas9 knockout screening in human cells.

Authors:  Ophir Shalem; Neville E Sanjana; Ella Hartenian; Xi Shi; David A Scott; Tarjei Mikkelson; Dirk Heckl; Benjamin L Ebert; David E Root; John G Doench; Feng Zhang
Journal:  Science       Date:  2013-12-12       Impact factor: 47.728

Review 5.  CRISPR-Cas systems for editing, regulating and targeting genomes.

Authors:  Jeffry D Sander; J Keith Joung
Journal:  Nat Biotechnol       Date:  2014-03-02       Impact factor: 54.908

6.  Notch-mediated expansion of human cord blood progenitor cells capable of rapid myeloid reconstitution.

Authors:  Colleen Delaney; Shelly Heimfeld; Carolyn Brashem-Stein; Howard Voorhies; Ronald L Manger; Irwin D Bernstein
Journal:  Nat Med       Date:  2010-01-17       Impact factor: 53.440

7.  Activation of concurrent apoptosis and necroptosis by SMAC mimetics for the treatment of refractory and relapsed ALL.

Authors:  Scott McComb; Júlia Aguadé-Gorgorió; Lena Harder; Blerim Marovca; Gunnar Cario; Cornelia Eckert; Martin Schrappe; Martin Stanulla; Arend von Stackelberg; Jean-Pierre Bourquin; Beat C Bornhauser
Journal:  Sci Transl Med       Date:  2016-05-18       Impact factor: 17.956

8.  CRISPR/Cas9 β-globin gene targeting in human haematopoietic stem cells.

Authors:  Daniel P Dever; Rasmus O Bak; Andreas Reinisch; Joab Camarena; Gabriel Washington; Carmencita E Nicolas; Mara Pavel-Dinu; Nivi Saxena; Alec B Wilkens; Sruthi Mantri; Nobuko Uchida; Ayal Hendel; Anupama Narla; Ravindra Majeti; Kenneth I Weinberg; Matthew H Porteus
Journal:  Nature       Date:  2016-11-07       Impact factor: 49.962

Review 9.  Is non-homologous end-joining really an inherently error-prone process?

Authors:  Mireille Bétermier; Pascale Bertrand; Bernard S Lopez
Journal:  PLoS Genet       Date:  2014-01-16       Impact factor: 5.917

10.  Lentiviral gene transfer into human and murine hematopoietic stem cells: size matters.

Authors:  Kirsten Canté-Barrett; Rui D Mendes; Willem K Smits; Yvette M van Helsdingen-van Wijk; Rob Pieters; Jules P P Meijerink
Journal:  BMC Res Notes       Date:  2016-06-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.